184 related articles for article (PubMed ID: 37520575)
1. Largely preserved functionality after the combined loss of NKG2D, NCR1 and CD16 demonstrates the remarkable plasticity of NK cell responsiveness.
Imširović V; Lenartić M; Wensveen FM; Polić B; Jelenčić V
Front Immunol; 2023; 14():1191884. PubMed ID: 37520575
[TBL] [Abstract][Full Text] [Related]
2. NK cell receptor NKG2D sets activation threshold for the NCR1 receptor early in NK cell development.
Jelenčić V; Šestan M; Kavazović I; Lenartić M; Marinović S; Holmes TD; Prchal-Murphy M; Lisnić B; Sexl V; Bryceson YT; Wensveen FM; Polić B
Nat Immunol; 2018 Oct; 19(10):1083-1092. PubMed ID: 30224819
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).
García-López R; de la Morena-Barrio ME; Alsina L; Pérez-Dueñas B; Jaeken J; Serrano M; Casado M; Hernández-Caselles T
PLoS One; 2016; 11(7):e0158863. PubMed ID: 27415628
[TBL] [Abstract][Full Text] [Related]
6. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
Vuletić A; Jurišić V; Jovanić I; Milovanović Z; Nikolić S; Konjević G
J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
[TBL] [Abstract][Full Text] [Related]
7. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
[TBL] [Abstract][Full Text] [Related]
8. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
[TBL] [Abstract][Full Text] [Related]
9. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
[TBL] [Abstract][Full Text] [Related]
10. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
11. Changes in natural killer cell subsets in pediatric liver transplant recipients.
Pham B; Piard-Ruster K; Silva R; Gallo A; Esquivel CO; Martinez OM; Krams SM
Pediatr Transplant; 2012 Mar; 16(2):176-82. PubMed ID: 22360401
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale Colocalization of NK Cell Activating and Inhibitory Receptors Controls Signal Integration.
Tomaz D; Pereira PM; Guerra N; Dyson J; Gould K; Henriques R
Front Immunol; 2022; 13():868496. PubMed ID: 35720315
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
[TBL] [Abstract][Full Text] [Related]
14. Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.
Shi L; Li K; Guo Y; Banerjee A; Wang Q; Lorenz UM; Parlak M; Sullivan LC; Onyema OO; Arefanian S; Stelow EB; Brautigan DL; Bullock TNJ; Brown MG; Krupnick AS
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):11808-11813. PubMed ID: 30381460
[TBL] [Abstract][Full Text] [Related]
15. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
16. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
[TBL] [Abstract][Full Text] [Related]
17. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
Hromadnikova I; Pirkova P; Sedlackova L
Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
Peipp M; Klausz K; Boje AS; Zeller T; Zielonka S; Kellner C
Clin Exp Immunol; 2022 Jul; 209(1):22-32. PubMed ID: 35325068
[TBL] [Abstract][Full Text] [Related]
19. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
Front Immunol; 2020; 11():202. PubMed ID: 32153568
[TBL] [Abstract][Full Text] [Related]
20. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
Magri G; Muntasell A; Romo N; Sáez-Borderías A; Pende D; Geraghty DE; Hengel H; Angulo A; Moretta A; López-Botet M
Blood; 2011 Jan; 117(3):848-56. PubMed ID: 21030563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]